FDA – Page 306 – Pharma.Tips

Aseptic Gowning Deviation after maintenance intervention: CAPA package with evidence and effectiveness checks

Aseptic Gowning Deviation Investigation Following Maintenance Activities In the highly regulated environment of pharmaceutical manufacturing, especially when managing parenteral dosage forms, aseptic gowning is a critical process that ensures product…

Filter Integrity Failure post-sterile filtration: CAPA package with evidence and effectiveness checks

Understanding and Addressing Filter Integrity Failure in Sterile Filtration Processes Filter integrity failures in sterile filtration processes are critical issues that can jeopardize the quality and safety of parenteral products.…

Emulsion Inversion at accelerated stability: GMP investigation and CAPA strategy

Understanding Emulsion Inversion at Accelerated Stability: A GMP Investigation Guide Emulsion inversion is a challenge that can arise during the stability testing of topical pharmaceutical forms. This issue has implications…

Media Fill Failure during routine EM trending: data integrity checks for lab and shop floor

Addressing Media Fill Failures Observed in Routine Environmental Monitoring: A Detailed Investigation Guide In the high-stakes environment of pharmaceutical manufacturing, particularly in parenteral dosage forms, the occurrence of media fill…

Media Fill Failure during routine EM trending: risk assessment for patient safety and recall

Risk Assessment and Investigation of Media Fill Failure during Routine EM Trending Media fill failures can be one of the most concerning issues in pharmaceutical manufacturing, particularly for sterile products.…

Phase Separation in cream manufacturing: mixing and sampling controls for QA review

Addressing Phase Separation in Cream Manufacturing: Practical Strategies for Quality Assurance Phase separation in cream manufacturing can significantly impact product quality and stability, leading to unacceptable deviations and potential regulatory…

Ccit Failure during power interruption: how to classify deviation and set disposition

Ccit Failure during Power Outages: Deviation Classification and Disposition Strategies In the realm of pharmaceutical manufacturing, power interruptions can pose serious challenges, especially for parenteral dosage forms requiring stringent storage…

Endotoxin Oos during campaign changeover: FDA/MHRA investigation narrative and batch impact

Investigating Endotoxin OOS Results During Campaign Changeovers in Pharma Manufacturing Endotoxin contamination can significantly disrupt parenteral manufacturing, particularly during campaign changeovers where different products are processed sequentially in the same…

Odor Change after excipient change: GMP investigation and CAPA strategy

GMP Investigation into Odor Change Following Excipient Modification In pharmaceutical manufacturing, the integrity of formulations is paramount, and even minor changes can yield significant sensory impacts. One such issue arises…

Bioburden Spike Pre-Filtration during routine EM trending: risk assessment for patient safety and recall

Addressing Bioburden Spikes Pre-Filtration during Routine Environmental Monitoring: A Comprehensive Investigation In modern pharmaceutical manufacturing, especially concerning parenteral dosage forms, bioburden control is paramount. A recent signal indicating unexpected spikes…

Particulate Matter Oos during hold-time study: how to classify deviation and set disposition

Classifying Deviations from OOS Results of Particulate Matter During Hold-Time Studies In the realm of pharmaceutical manufacturing, maintaining compliance with stringent regulatory standards is paramount. An unexpected Out-of-Specification (OOS) result…

Tube Leakage Complaint in cream manufacturing: complaint trending and risk-based actions

Investigating Tube Leakage Complaints in Cream Manufacturing: Trending and Risk Mitigation Strategies In the realm of pharmaceutical manufacturing, particularly in topical dosage forms such as creams, tube leakage complaints can…